Home Exuma Biotech

Exuma Biotech

In operation
Series B
CAR-T Cell Product Developer
Basic
Enterprise Profile

Basic Information

Exuma Biotech is a clinical-stage biotechnology company focused on discovering and developing CAR-T cell products for solid tumors. They have developed new tools for the patient's immune system to combat various solid tumor malignancies, such as renal cell carcinoma, soft tissue sarcoma, gastric cancer, etc.
EXUMA BIOTECH CORP.
Florida,United States of America
15~50 people
January 01, 2015
--

Enterprise Profile

Industrial Sector
New Drug Development Scientific Research and Experimental Development Services Immune Cell Therapy
Concept
Disease Treatment Immune System Diseases Gastric Cancer
Application Scenarios
Innovative Drugs